<DOC>
	<DOCNO>NCT01845142</DOCNO>
	<brief_summary>Vitamin D receptor express activated different immune cell . It known , immune cell type target exogenous vitamin D. Here , vitamin D-deficient individual receive 100.000 I.U . vitamin D3 either intramuscular subcutaneous double-blind placebo control setting . Immune cell monitor blood time .</brief_summary>
	<brief_title>Immunologic Action Single Dose Cholecalciferol</brief_title>
	<detailed_description>Vitamin D-deficient individual receive - double-blind , placebo control 100.000 I.U.vitamin D3 - intramuscular subcutaneous Blood take time - immune cell ( T cell , B cell , myeloid antigen present cell ) characterize flow-cytometry - vitamin D-metabolites monitor</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>inform consent 1860 yr 25hydroxyvitamin D serum 50 nmol/L woman : effective contraception 25hydroxyvitamin D serum 50 nmol/L bodymass index &lt; 18 &gt; 30 kg per m2 plan UVexposure ( UVindex &gt; 5 ) hypersensitivity vitamin D history hypercalcemia , kidney stone , kidney insufficiency , sarcoidosis , pseudohyperparathyroidism concomitant vitamin A and/or vitamin D treatment treatment immunosuppressant , immunomodulators , phenytoin , barbiturate , thiazidediuretics , glycoside immobile patient normal range screen visit ( calcium , phosphate , creatinin , hematology ) psychiatric hospitalization pregnancy / breastfeeding dependency / relationship sponsor concomitant participation clinical trial ( 30 day ) drug alcohol abuse lack compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>vitamin D deficiency</keyword>
	<keyword>immune cell</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>&lt; 50 nmol/L 25 ( OH ) D serum concentration</keyword>
</DOC>